Endometrial preparation for frozen-thawed embryo transfer with and without gonadotropin releasing hormone agonist

Endometrial preparation for frozen-thawed embryo transfer without gonadotropin releasing hormone agonist effect on the pregnancy results

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201109224572N2

Enrollment

100

Registered

2011-10-17

Start date

2008-07-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Female infertility. Female infertility

Interventions

Intervention 1: Control group : No intervention. Intervention 2: Intervention group: the two cycles were cancelled, GnRh agonist (buserelin) wasn’t administered in the luteal phase.

Treatment - Drugs

Control group : No intervention

Intervention group: the two cycles were cancelled, GnRh agonist (buserelin) wasn’t administered in the luteal phase

Eligibility

Sex/Gender

Female

Age

25 Years to 38 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: presence of functioning ovary, normal cavity of uterus, age 25 to 38 years old, presence of infertility Exclusion criteria: uterine anomaly, FSH more than 11, endometriosis, hypothalamic amenorrhea

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Pregnancy rate. Timepoint: pregnancy test was performed 15 days after transfer. Method of measurement: B HCG above 10 is considered positive.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShohre Movahedi

Tehran University of Medical Sciences

shmovahedy@razi.tums.ac.ir+98 21556585004

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026